Evidence map›Paper›PMID 33076988›Full record

ArticleClinical epigenetics2020

Novel mutation points to a hot spot in CDKN1C causing Silver-Russell syndrome.

Gerhard Binder, Julian Ziegler, Roland Schweizer, Wisam Habhab, Tobias B Haack, Tilman Heinrich, Thomas Eggermann

Open access · goldAbstract read
In one paragraph

Article in Clinical epigenetics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 21 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Approach to the Patient With Suspected Silver-Russell Syndrome.The Journal of clinical endocrinology and metabolism · 2024
    Review
  6. Review
  7. Article
  8. Article
  9. World journal of clinical cases · 2023
    Article
  10. Article
  11. Deep exploration of aJournal of medical genetics · 2022
    Article
  12. Article
  13. Isolated Hypomethylation ofDiagnostics (Basel, Switzerland) · 2021
    Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Gerhard BinderPediatric Endocrinology, University Children's Hospital, Hoppe-Seyler-Strasse 1, 72076, Tübingen, Germany. gerhard.binder@med.uni-tuebingen.de.ORCID 0000-0001-7988-3587
Julian ZieglerPediatric Endocrinology, University Children's Hospital, Hoppe-Seyler-Strasse 1, 72076, Tübingen, Germany.
Roland SchweizerPediatric Endocrinology, University Children's Hospital, Hoppe-Seyler-Strasse 1, 72076, Tübingen, Germany.
Wisam HabhabInstitute of Medical Genetics and Applied Genomics, University of Tübingen, Tübingen, Germany.
Tobias B HaackInstitute of Medical Genetics and Applied Genomics, University of Tübingen, Tübingen, Germany.
Tilman HeinrichInstitute of Medical Genetics and Applied Genomics, University of Tübingen, Tübingen, Germany.
Thomas EggermannInstitute of Human Genetics, Medical Faculty, RWTH Aachen University, Aachen, Germany.
University Children's Hospital Tübingen · DEUniversity of Tübingen · DERWTH Aachen University · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPathogenic CDKN1C gain-of-function variants on the maternal allele were initially reported as a cause of IMAGe syndrome characterized by intrauterine growth retardation, metaphyseal dysplasia, primary adrenal insufficiency and genital anomalies. Recently, a maternally inherited CDKN1C missense mutation (p.Arg279Leu) was identified in several members of a single family clinically diagnosed with Silver-Russell syndrome (SRS) but without adrenal insufficiency. Thereafter, two half siblings from UK with familial SRS were described who carried the same mutation. This specific amino acid change is located within a narrow functional region containing the mutations previously associated with IMAGe syndrome.

resultsHere, we describe a third familial case with maternally inherited SRS due to a missense variant affecting the same amino acid position 279 but leading to a different amino acid substitution (p. (Arg279Ser)). The two affected family members (mother and son) presented with the complete SRS phenotype (both Netchine-Harbison CSS score 5 of 6) but without body asymmetry or adrenal insufficiency.

conclusionsIn comparison with loss-of-function genomic IGF2 mutations, CDKN1C gain-of-function mutations are a less frequent cause of SRS and seem to affect a cluster of few amino acids.

Indexed as

Adrenal InsufficiencyAllelesAmino Acid SubstitutionChild, PreschoolCyclin-Dependent Kinase Inhibitor p57FemaleFetal Growth RetardationGenetic VariationHeterozygoteHuman Growth HormoneHumansInsulin-Like Growth Factor IIMaleMothersMutation, MissenseOsteochondrodysplasiasCDKN1C protein, humanCyclin-Dependent Kinase Inhibitor p57Human Growth HormoneIGF2 protein, humanInsulin-Like Growth Factor IICDKN1CGrowth retardationSilver–Russell syndrome

Identifiers

PMID33076988
PMCPMC7574352
OpenAlexW3092683252

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.